September 30, 2020
New results published in the journal Biofabrication may help researchers on their quest to regenerate vascularized tissues.
August 12, 2019
Today, we have to share some bad news about Organovo and its liver tissue bioprinting program. Present state and future steps Organovo, a biotechnology company currently valued at $45M and most well-known for researching bioprinting technologies - the creation of artificial organs - has recently announced that it is suspending its artificial liver tissue program...